9,305 reports of this reaction
2.9% of all INTERFERON BETA 1A reports
#5 most reported adverse reaction
MULTIPLE SCLEROSIS is the #5 most commonly reported adverse reaction for INTERFERON BETA 1A, manufactured by Biogen Inc.. There are 9,305 FDA adverse event reports linking INTERFERON BETA 1A to MULTIPLE SCLEROSIS. This represents approximately 2.9% of all 322,666 adverse event reports for this drug.
Patients taking INTERFERON BETA 1A who experience multiple sclerosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MULTIPLE SCLEROSIS is a less commonly reported adverse event for INTERFERON BETA 1A, but still significant enough to appear in the safety profile.
In addition to multiple sclerosis, the following adverse reactions have been reported for INTERFERON BETA 1A:
The following drugs have also been linked to multiple sclerosis in FDA adverse event reports:
MULTIPLE SCLEROSIS has been reported as an adverse event in 9,305 FDA reports for INTERFERON BETA 1A. This does not prove causation, but indicates an association observed in post-market surveillance data.
MULTIPLE SCLEROSIS accounts for approximately 2.9% of all adverse event reports for INTERFERON BETA 1A, making it a notable side effect.
If you experience multiple sclerosis while taking INTERFERON BETA 1A, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.